two new investigational drugs for type 2 diabetes, Januvia and Galvus
July 2006
There's lots of buzz coming out of the latest American Diabetes Assoc meeting about two new investigational drugs for type 2 diabetes, Januvia and Galvus.
They're in a new class...DPP-4 inhibitors. They increase incretin. Watch for them later this fall and next year.
If you need info now, get our Detail-Document.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote